Mycophenolate mofetil treatment of crescentic Henoch-Schönlein nephritis with IgA depositions

Scandinavian Journal of Urology and Nephrology

Volumn 42, Issue 2, 2008, Pages 178-180

  Dede, Fatih ^a   Onec, Birgul ^a   Ayli, Deniz ^a   Gonul, Ipek Isik ^b   Onec, Kursad ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Crescentic glomerulonephritis; Henoch Sch nlein nephritis; Henoch Sch nlein purpura; Mycophenolate mofetil; Nephrotic syndrome

Indexed keywords

CHOLESTEROL; CORTICOSTEROID; CREATININE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTOXIFYLLINE; PREDNISOLONE; PROTEIN; RAMIPRIL; SERUM ALBUMIN; TRIACYLGLYCEROL; UREA;

ABDOMINAL RADIOGRAPHY; ADD ON THERAPY; ADULT; ALBUMIN BLOOD LEVEL; ANAPHYLACTOID PURPURA; ARTICLE; BLOOD CELL COUNT; CAPILLARY PROLIFERATION; CASE REPORT; CELL INFILTRATION; CHOLESTEROL BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG WITHDRAWAL; ECHOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOFLUORESCENCE TEST; IMMUNOGLOBULIN DEPOSITION; INTERSTITIAL NEPHRITIS; IRON DEFICIENCY ANEMIA; KIDNEY BIOPSY; KIDNEY CORTEX NECROSIS; LABORATORY TEST; LONG TERM CARE; NEPHROTIC SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROMYELOCYTE; PROTEIN BLOOD LEVEL; PROTEINURIA; PURPURIC RASH; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; TRIACYLGLYCEROL BLOOD LEVEL; UREA BLOOD LEVEL; URINALYSIS; VITAL SIGN;

ADULT; BIOPSY; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; MYCOPHENOLIC ACID; PRODRUGS; PURPURA, SCHOENLEIN-HENOCH; REMISSION INDUCTION;

EID: 41349104301     PISSN: 00365599     EISSN: 16512065     Source Type: Journal    
DOI: 10.1080/00365590701571514     Document Type: Article

References (9)

1. Rostoker G. Schönlein-Henoch purpura in children and adults. BioDrugs 2001;15(2):99-138.
2. Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D. Henoch-Schönlein purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 2002;13:1271-8.
3. Chan TM, Tse KC, Tang CSO, Mok MY, Li FK. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis. J Am Soc Nephrol 2005;16:1076-84.
4. Bergner R, Hoffmann M, Brass H, Uppenkamp M. Therapy of IgA nephropathy with mycophenolate mofetil - report of 3 cases. Clin Nephrol 2004;61(3):207-12.
5. Choi MJ, Eustace JA, Gimenez LF, Atta MG, Scheel PJ, Sothinathan R, et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002;61:1098-114.
6. Nowack R, Birck R, van der Woude FJ. Mycophenolate mofetil for systemic vasculitis and IgA nephropathy. Lancet 1997;349(9054):774.
7. Maes BD, Oyen R, Claes K, Evenepoel P, Kuypers D, Vanwalleghem J, et al. Mycophenolate mofetil in IgA nephropathy: result of a 3 year prospective placebo-controlled randomized study. Kidney Int 2004;65:1842-9.
8. Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, et al. Mycophenolate mofetil (MMF) vs placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 2005;20:2139-45.
9. Tang S, Leung JC, Chan LY, Lui YH, Tang CS, Kan CH, et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005;68(2):802-12.